A jarring new study has revealed that Parkinson’s disease cases worldwide are on track to more than double over the next three decades, highlighting an urgent need for greater awareness and ...

Walter and Eliza Hall Institute’s (WEHI) Parkinson’s Disease Research Centre has solved the mystery by determining the structure of human PINK1 when attached to the mitochondria (1 ...

A concerning new study reveals that Parkinson’s disease cases worldwide are projected to increase by 112 percent between 2021 and 2050, rising from nearly 12 million to an estimated 25.2 million ...

Mar. 9, 2025 — A recently launched Phase 1 clinical trial is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem cells ...

LAKELAND, Fla. — Kirk Gibson, who has waged a public battle against Parkinson's disease, is stepping down as a member of the Tigers broadcasts this season on FanDuel Sports Network to focus on ...

Scientists have made a potentially “life-changing” discovery that could pave the way for new drugs to treat Parkinson’s disease. Experts have known for several decades that the PINK1 protein ...

RAGTAG tribal warriors are using bows and arrows to fight AI drones and elite special forces in a brutal conflict that is set to erupt into all out war, an exiled leader has warned. The simmering ...

The US Senate has joined the House of Representatives in approving the first-ever federal bill dedicated to ending Parkinson’s disease, modelled on similar legislation for Alzheimer’s that was ...

Bayer subsidiary BlueRock Therapeutics has been granted a fast-track review by the FDA for DA01, its stem cell-based therapy for Parkinson's disease which is currently in early-stage clinical testing.

C Klein is a Lichtenberg Professor of Clinical and Molecular Neurogenetics at the Department of Neurology at Lübeck University, Lübeck, Germany; MG Schlossmacher is an assistant professor of ...